Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2022-03-01 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-014408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | 2022-03-01 | SRPT | Estepan Ian Michael | CFO | F - Tax | $75.05 | -376 | 26.4K | -1% | -$28.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | F | D | 376 | $75.05 | 26,377 | D | — | — | (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. |